Opportunities or Challenges: Need for Transparent Consultation and Reality-Based Thinking on Canadian Drug Pricing and Access to Innovation; How to Make PMPRB Guidelines, HTA, and National Pharmacare Work for Patients Neil Palmer, PDCI Market Access Inc